Plus Therapeutics Provides Updates on ReSPECT™ Clinical Trials at the 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

November 19, 2022

https://www.globenewswire.com/news-release/2022/11/19/2559472/0/en/Plus-Therapeutics-Provides-Updates-on-ReSPECT-Clinical-Trials-at-the-27th-Annual-Scientific-Meeting-and-Education-Day-of-the-Society-for-Neuro-Oncology.html

ReSPECT-GBM clinical trial of rhenium (186Re) obisbemeda in recurrent glioblastoma continues to demonstrate safety and overall survival correlates with radiation dose to tumor

Read more at globenewswire.com

Related news for (PSTV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.